|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.375 USD | +0.15% |
|
-6.16% | +4.69% |
| Capitalization | 71.93M 61.59M 57.28M 53.4M 99.78M 6.48B 107M 660M 259M 3.1B 270M 264M 11.37B | P/E ratio 2026 * |
-15.3x | P/E ratio 2027 * | 337x |
|---|---|---|---|---|---|
| Enterprise value | 10.18M 8.72M 8.11M 7.56M 14.12M 917M 15.15M 93.38M 36.7M 439M 38.17M 37.39M 1.61B | EV / Sales 2026 * |
0.05x | EV / Sales 2027 * | 0.01x |
| Free-Float |
91.92% | Yield 2026 * |
-
| Yield 2027 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: PetMed Express, Inc.
More recommendations
More press releases
| 1 day | +0.30% | ||
| 1 week | -6.16% | ||
| Current month | +4.69% | ||
| 1 month | +16.72% | ||
| 3 months | +34.54% | ||
| 6 months | +5.02% | ||
| Current year | +4.69% |
| 1 week | 3.23 | 3.6 | |
| 1 month | 2.78 | 4.1 | |
| Current year | 3.18 | 3.7 | |
| 1 year | 1.57 | 5.58 | |
| 3 years | 1.57 | 22.64 | |
| 5 years | 1.57 | 57 | |
| 10 years | 1.57 | 57.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Leslie Campbell
CEO | Chief Executive Officer | 68 | 2025-08-10 |
Doug Krulik
DFI | Director of Finance/CFO | 57 | 2025-08-10 |
| Chief Operating Officer | - | 2024-06-02 |
| Director | Title | Age | Since |
|---|---|---|---|
Gian Fulgoni
CHM | Chairman | 78 | - |
Leslie Campbell
CHM | Chairman | 68 | 2024-01-04 |
Justin Mennen
BRD | Director/Board Member | 45 | 2024-06-02 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.15% | -6.16% | -30.93% | -82.49% | 71.93M | ||
| -1.01% | -3.18% | +14.32% | +3.57% | 7.72B | ||
| -0.05% | -1.84% | +52.54% | +9.71% | 1.45B | ||
| -2.10% | -1.44% | +45.47% | +81.77% | 498M | ||
| +5.03% | +6.33% | +43.92% | +18.35% | 70.08M | ||
| Average | +0.43% | -0.83% | +25.06% | +6.18% | 1.96B | |
| Weighted average by Cap. | -0.87% | -2.38% | +21.41% | +7.92% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 199M 170M 159M 148M 276M 17.94B 296M 1.83B 718M 8.58B 747M 731M 31.47B | 205M 176M 163M 152M 284M 18.48B 305M 1.88B 739M 8.84B 769M 753M 32.41B |
| Net income | -4.57M -3.91M -3.64M -3.39M -6.34M -412M -6.8M -41.91M -16.47M -197M -17.13M -16.78M -722M | 261K 224K 208K 194K 363K 23.57M 389K 2.4M 943K 11.27M 981K 960K 41.34M |
| Net Debt | -61.75M -52.88M -49.17M -45.84M -85.66M -5.57B -91.88M -566M -223M -2.66B -232M -227M -9.76B | -70.5M -60.37M -56.14M -52.34M -97.79M -6.35B -105M -647M -254M -3.04B -264M -259M -11.15B |
More financial data
* Estimated data
Employees
173
Sector
Drug Retailers
Calendar
01-21
- Annual General Meeting
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-01-13 | 3.355 $ | -0.45% | 153,990 |
| 26-01-12 | 3.370 $ | +1.51% | 190,341 |
| 26-01-09 | 3.320 $ | 0.00% | 287,081 |
| 26-01-08 | 3.320 $ | -1.48% | 295,738 |
| 26-01-07 | 3.370 $ | -5.60% | 373,614 |
Delayed Quote Nasdaq, January 13, 2026 at 11:26 am
More quotesSell
Buy

Mean consensus
SELL
Number of Analysts
1
Last Close Price
3.370USD
Average target price
2.750USD
Spread / Average Target
-18.40%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PETS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
















